This article discusses the growing use of artificial intelligence (AI) in drug discovery, which combines computational techniques and machine learning models to accelerate the process of finding potential therapeutic candidates. AI is becoming a crucial tool in healthcare, particularly in medicine manufacturing, and is being leveraged by biopharmaceutical companies to increase their market presence. The article also highlights the challenges and opportunities of using AI in drug discovery.
